Today, Cynata's CEO and MD, Dr Kilian Kelly and CBO Dr Mathias Kroll, provided an update to investors, following the release of the ASX Quarterly Activity Report for the March 2025 quarter.

Cynata's CEO and MD, Dr Kilian Kelly, appeared on ausbiz TV to discuss Cynata's role in the newly funded SMART CRC initiative.

Watch the full interview to learn how this government-backed collaboration will help accelerate the development and commercialisation of next-generation cell therapies in Australia: ausbiz TV

Earlier today, Cynata's CEO and MD was featured on the Progress, Potential, And Possibilities podcast with Ira Pastor. Watch the interview here:

Following the release of our ASX Quarterly Activity Report for the period ending 31 December 2024, leading small business journalist Tim Boreham covered our highlights and milestones.

Read his article here: https://tinyurl.com/yda8z87h